Clinical and pathological features of an Alzheimer's disease patient with the MAPT ΔK280 mutation
Parastoo Momeni(Texas Tech University), Rohan de Silva(Mayo Clinic in Florida), Connie Luk(National Hospital for Neurology and Neurosurgery), Alan Pittman(St George's, University of London), Tammaryn Lashley(National Hospital for Neurology and Neurosurgery), Elke Malzer(University of Cambridge), Jana Vandrovcová(Texas Tech University), Andrew J. Lees(Centre for Movement Disorders), Tamás Révész(UCL Australia), Christine Hulette(St George's, University of London), John Hardy(UK Dementia Research Institute)
Cited by 66
Related Papers
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
|Neurology|1993|3.8k
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
|Nature Genetics|2009|3.4k
Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk
|Nature Genetics|2019|2.5k
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
|Nature Genetics|2011|2.1k